Codes / ICD10CM / O36.012

O36.012 Maternal care for anti-D [Rh] antibodies, second trimester

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Maternal care for anti-D [Rh] antibodies, second trimester
  • ICD Code: O36.012

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the second trimester who has anti-D (Rh) antibodies. The focus is on managing the risk of hemolytic disease in the fetus or newborn, which can occur if the fetus is Rh-positive. Care includes assessment of antibody levels, fetal monitoring, and planning for potential interventions to prevent or treat complications.

Causes

The presence of anti-D antibodies typically results from prior exposure to Rh-positive blood, such as during a previous pregnancy with an Rh-positive fetus, blood transfusion, or trauma. These antibodies can cross the placenta and attack the red blood cells of an Rh-positive fetus, leading to hemolysis.

Risk Factors

  • Previous pregnancy with an Rh-positive fetus
  • Blood transfusion with Rh-positive blood
  • Trauma or procedures (e.g., amniocentesis) during pregnancy that may cause fetal-maternal bleeding
  • Unknown prior sensitization (e.g., from unrecognized fetal-maternal hemorrhage)

Symptoms

  • No direct maternal symptoms; the condition is identified through laboratory testing
  • Potential fetal complications (e.g., anemia, hydrops fetalis) may develop, but these are not maternal symptoms

Diagnosis

Diagnosis involves testing the mother's blood for anti-D antibodies. Fetal monitoring may include Doppler ultrasound to assess for anemia or other signs of hemolysis. Additional tests, such as amniocentesis or cordocentesis, may be performed if needed.

Treatment Options

  • Monitoring of antibody levels and fetal status
  • Administration of Rh immunoglobulin (RhoGAM) if indicated
  • Intrauterine transfusions for severe fetal anemia
  • Planning for delivery timing and neonatal care

Prognosis and Follow-Up

With appropriate monitoring and intervention, outcomes for both mother and fetus are generally favorable. Follow-up includes continued fetal surveillance and postpartum care for the newborn.

Complications

  • Severe fetal anemia
  • Hydrops fetalis
  • Kernicterus (bilirubin-induced brain damage)
  • Increased risk of preterm birth

Lifestyle & Prevention

  • Ensure timely administration of Rh immunoglobulin after sensitizing events
  • Avoid unnecessary invasive procedures during pregnancy
  • Maintain regular prenatal care

When to Seek Professional Help

Seek medical attention if there are signs of fetal distress, such as reduced fetal movement, or if complications like preeclampsia develop.

Tips for Medical Coders

Document the trimester (second trimester) and the presence of anti-D antibodies. Include details of monitoring, interventions, and fetal status to support code assignment. Ensure documentation aligns with the specific care provided during this period.

Book a walkthrough

O36.012 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.